Bank of New York Mellon Corp - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 69 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2022$305,000
-23.6%
1,321,327
+18.4%
0.00%
Q4 2021$399,000
-33.8%
1,115,899
+11.2%
0.00%
Q3 2021$603,000
-43.7%
1,003,331
+4.0%
0.00%
Q2 2021$1,071,000
+410.0%
965,153
+489.2%
0.00%
Q1 2021$210,000163,8150.00%
Other shareholders

There were no reported owners of TONIX PHARMACEUTICALS HLDG C in Q1 2021.

NameSharesValueWeighting ↓
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders